Search Results 431-440 of 18383 for total bilirubin

  1. Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma - Mayo Clinic

    Total bilirubin ≤ 1.5 x upper limit of normal (ULN) or if total bilirubin is > 1.5 x ULN, the direct bilirubin must be normal; Alkaline (Alk.) phosphatase ...

  2. A Study Of BMS-986340 In Combination With Nivolumab, Gemcitabine And Nab-paclitaxel In The First Line Setting Of Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

    Total bilirubin ≤ 1.5 x ULN, except in patients with documented Gilbert's syndrome, who must have a total bilirubin ≤ 3 x ULN. Aspartate aminotransferase ...

  3. Intravesical Administration of INSTILADRIN (rAd-IFN With Syn3) in Patients With Bladder Cancer - Mayo Clinic

    Total bilirubin within institutional normal limits. Creatinine ≤1.5 x ULN. Exclusion Criteria: Current or previous evidence of muscle invasive or ...

  4. Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer) - Mayo Clinic

    Total serum bilirubin ≤ ULN; or total bilirubin ≤ 3.0 × ULN with direct bilirubin within normal range in subjects with documented Gilbert's Syndrome ...

  5. Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence - Mayo Clinic

    Total bilirubin ≤ 1.5 × upper limit of normal (ULN) (except patients with Gilbert Syndrome, who must have total bilirubin < 3.0 mg/dL);; Alanine ...

  6. CATALINA-2: A Clinical Study Of TORL-1-23 In Platinum-resistant Ovarian Cancer.

    ... Serum total bilirubin: ≤1.5 X ULN (participants with known Gilbert disease or liver metastases who have serum bilirubin level ≤3×ULN may be enrolled * AST ...

  7. Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed By Surgery - Mayo Clinic

    Total bilirubin ≤3.0 x upper limit of normal (ULN); SGOT (AST) ≤5 x ULN. SGPT (ALT) ≤5 x ULN. Creatinine ≤1.5 x ULN. INR ≤1.5 x ULN. Patients receiving ...

  8. Clinical Trials - Tesevatinib in Subjects With ADPKD

    Total bilirubin ≤ 1.5 mg/dL;; Aspartate aminotransferase < 2.5 × ULN;; Alanine aminotransferase < 2.5 × ULN;; Prothrombin time/partial thromboplastin time ...

  9. A Study to Evaluate the Effectiveness and Safety of PCS499 in Treating Ulcerations in Patients who have Necrobiosis Lipoidica - Mayo Clinic

    Total bilirubin level ≥ 2 x ULN unless the individual has been diagnosed with Gilbert's disease and this is clearly documented. Estimated glomerular ...

  10. Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer - Mayo Clinic

    ... total bilirubin ≤ 2.0 times ULN and direct bilirubin within normal limits are permitted. Aspartate aminotransferase (AST) (serum glutamic oxaloacetic ...